Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Small Cell Lung Carcinoma × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 7 Neoplasms 6 Neoplasm Metastasis 5 Carcinoma 4 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 NSCLC 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchial Neoplasms 1

Interventions

Carboplatin 39 Etoposide 33 Cisplatin 21 Topotecan 20 Nivolumab 13 atezolizumab 10 pembrolizumab 9 Ipilimumab 9 durvalumab 8 Paclitaxel 7 Irinotecan 7 rovalpituzumab tesirine 5 Radiosurgery 5 trioctyl phosphine oxide 4 trilaciclib 4 berzosertib 4 Sunitinib 4 Platinum 4 Pemetrexed 4 PM 01183 4 veliparib 3 tremelimumab 3 olaparib 3 carfilzomib 3 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 Drug Therapy 3 Doxorubicin 3 Dexamethasone 3 Bevacizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡